Disease advocacy organizations catalyze translational research

13Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

Disease advocacy organizations have long played an important role in the continuum from basic science to therapy development in rare disease research. PXE International has led the field in innovative ways, venturing into specific activities that have traditionally been conducted by scientists. As lay founders, we have engaged in gene discovery, gene patenting, diagnostic test development, epidemiological studies, clinical trials, and therapy research and development. This article will describe the steps that we took, and the ways in which we have scaled these efforts for the larger community. © 2013 Terry.

Cite

CITATION STYLE

APA

Terry, S. F. (2013). Disease advocacy organizations catalyze translational research. Frontiers in Genetics, 4(JUN). https://doi.org/10.3389/fgene.2013.00101

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free